Zach Conrad died on a lovely Sunday afternoon in Philadelphia. It was 3 June 2012, and the 36-year-old financial analyst had decided to take a solo bike ride, as he often did on weekends. As the ride progressed, however, Conrad sensed that something was wrong. He pulled over to the side of the road, took off his helmet and slumped to the ground. His heart stopped beating and he stopped breathing. He was having a sudden cardiac arrest.
The odds weren’t on Conrad’s side that day. Each year, around 300,000 people in the US suffer a cardiac arrest. Most victims die: of those who make it to the hospital, 85-90% leave in a box or a bag.
But instead of adding to that sorry figure, Conrad was about to join a group of people who are challenging our notions of mortality. In some communities, up to 30-40% of arrest victims leave the hospital alive. One likely difference is that these lucky few wound up at a hospital that implements the latest practices in resuscitation science.
Conrad made it to one such resuscitation facility, at the University of Pennsylvania, but his route to get there was circuitous. The emergency crew first rushed him to a local hospital, but staff there were unsure of what was wrong with Conrad – he was hardly the typical heart attack victim – and did not know what course of action would best aid his survival and recovery. Conrad’s wife, a doctor, had by then arrived. She recalled hearing about resuscitation research taking place at the nearby university, and insisted Conrad be transferred.
By that evening, he was admitted to the University of Pennsylvania’s hospital, where Benjamin Abella, a physician and the clinical research director at the Center for Resuscitation Science, ordered that Conrad should undergo a 24-hour cooling treatment to reduce inflammation and slow metabolism – two components that seem to be key for helping the body recover from resuscitation injury. Following that treatment, Conrad lay in a medically induced coma for several days, during which time he received post-arrest care, including blood pressure support, cardiac catheterisation and mechanical ventilation. On Friday, he regained consciousness.
“It is conceivable that, had I stayed at the local hospital, I’d have been just fine and would have recovered – that I don’t know,” Conrad says. “But I’m happy I wasn’t the control.”
Cases like Conrad’s are far from unheard of. And they are helping physicians and scientists who specialise in resuscitation tease out the mechanisms governing the death process. Their ultimate goal is to halt and reverse that process. “When you’re freshly dead, your brain isn’t necessarily irreversibly, irrefutably damaged yet,” explains Sam Parnia, a critical care physician and director of resuscitation research at Stony Brook University School of Medicine in New York. “You have to both die and have brain death to really be dead.”
In fact, as new technology and knowledge of the body enhances our proficiency at resuscitation, it is transforming our ideas about the nature of death itself. Researchers are coming to understand that death occurs more on a sliding scale than at a single moment. In other words, we often do not die all at once. Even if the heart has stopped, the body can remain alive for hours – some parts even days. “At this point we’ve got two domains: the slightly dead and the very dead, for lack of better terms,” says Abella. “Or the not-quite-dead-yet. It’s definitely getting blurry.”
Death is a necessary caveat for every living thing and – as the sole species (we think) capable of conceiving of its own demise – it’s constantly on our minds. Yet the more we learn, the more we realise how crude our understanding of death actually is.
Most people consider death as a single moment – a person is present, and then he or she is not. It is the turning off of life’s switch, typically registered as the moment that person’s heart stops beating. Today, around 95% of death certificates use this event to note the time of passing, and for the vast majority of human history, this thinking reflected reality. If a person’s heart stopped beating, he or she had been issued a death sentence. There was no bringing them back.
In the early 1960s, however, researchers began to challenge that assumption. Closed chest compressions combined with mouth-to-mouth breathing could alter a person’s fate by restarting their heart. Even then, doctors presumed that within moments after blood ceases to flow the victim’s brain begins to break down, soon rendering them into a vegetative state – even if their heart was restarted.
“We were all taught that we have five minutes after the heart stops,” Parnia says. “Now we realise that’s outdated, that in fact brain cells don’t die immediately.”
Researchers now understand that cells and organs undergo their own deaths, a process that can take hours or even days depending upon circumstances. In an extreme example, muscle stem cells can remain viable in human cadavers for up to 17 days, a 2012 study found, so long as they are not contaminated by oxygen.
A person who does not respond after 20 to 30 minutes of resuscitation efforts will probably not make a meaningful recovery, but that time limit is not set. Science is far from establishing when a body’s capacity for consciousness actually leaves it. “We don’t know how long it takes after death for the cells to decay to such a point that no matter what you do, you can never get them back again,” Parnia says.
Which means that humans may take hours to fully die. In a remarkable 2011 case, a woman in Japan, intent on committing suicide, wandered into a forest and overdosed on pills. The next morning, a passerby found her. When emergency personnel arrived, her body temperature was 20C. She had no pulse and was not breathing. Efforts to shock her heart into action failed, but rather than send her to the morgue, doctors connected her to an extra-corporeal membrane oxygenation (ECMO) machine – a device that acts as an artificial lung and heart, and is a standard of care in Japan – and left her to circulate.
Several hours into the procedure, her heart fluttered back to life. The woods’ cool temperature, it turned out, had prevented the woman’s cells from breaking down as quickly as they would have in a warmer environment, allowing her to lay dead in the forest for around four hours, plus survive an additional six hours between the time the passerby called the ambulance and the time her heart began beating again. Three weeks later, she left the hospital, and today she is happily married and recently delivered a baby. “If one of our [emergency medical service] crews found that young girl, she would have just been declared dead,” Parnia says.
Conquering death, like any disease, requires knowing the enemy and devising ways to combat it, Parnia explains in his book, Erasing Death. The first step is simply getting the patient’s heart to restart. Special defibrillators can boost the odds of success by monitoring CPR on the spot. They provide audio and visual coaching to optimise a doctor’s performance, such as instructing him to push harder or to allow more time between compressions. The devices also store data for later review. Most doctors, however, do not bother with these machines, though data indicate that they should. In one study, initial CPR success rates averaged at 45%, but making doctors use the feedback-providing defibrillator pushed up success rates to 60%.
To buy time, ECMO devices like the one used in the Japanese woman’s case can keep the body functioning until doctors can get the heart restarted. These machines remove the patient’s blood and then circulate it back into the body full of oxygen. In South Korea and Japan, doctors have reported up to 90% success rates in restarting the heart using ECMO devices. In the US and Europe (where doctors typically report a 50% success rate in restarting the heart), however, no standardised procedures exist for implementing ECMO machines.
Even if a doctor successfully restarts a patient’s heart, it is often a short-lived victory. As scientists tease out the mechanisms of death at the biological level, they are beginning to learn that some standard critical-care practices – flooding a cardiac arrest victim’s system with oxygen and increasing their blood pressure immediately following the heart attack – are not the best way to ward off an ensuing cascade of cellular suicide.
Cooling down the body is probably the most important breakthrough in increasing the chances that those cells stop their death rampage. Since 2003, some hospitals have been championing this mild form of hypothermia – the same procedure that Conrad underwent after his heart attack. Doctors lower the patient’s temperature by around four degrees, to 33C, using either liquid-filled pads or catheters that cool him or her from the inside. This sends the body into a hibernation-like state, allowing it time to recover from the injury and trauma of cardiac arrest. It lessens swelling and pressure on the brain and reduces cellular activity, including cells’ instructions to commit suicide. One study found that for every six patients who undergo this treatment, one benefited.
Combining all of these methods – from the time a person first suffers a heart attack to the critical period after – increased patient survival from 26 to 56%, according to a 2007 study in conducted Norway. Of those survivors, 90% did not suffer any long-term neurological or physical repercussions.
All of which suggests that the accumulating information and techniques are beginning to slide the scale in our favour. “In biology, if you can do it once, it’s very likely you can do it a second time,” says Lance Becker, director of Penn’s Center for Resuscitation Science. “And if you work it out, you can do it every time.”
Resuscitation is still a very young field, however, and experts say there are several major areas to tackle. For instance, there are no scientifically validated guidelines about when to stop a resuscitation effort for a particular patient. Current efforts are “frighteningly variable”, Becker said in a recent panel discussion at the New York Academy of Sciences. A 2012 study examining current practices across 435 US hospitals demonstrated this. In analysis of more than 64,000 events, the authors found that the majority of doctors stop their efforts at 20 minutes if the patient did not respond. However, hospitals with the shortest resuscitation attempts for non-survivors – 16 minutes – saved significantly fewer cardiac arrest patients than those that put in 25 minutes – just 10 extra minutes of effort. “If a doctor just stops in an arbitrary fashion, for the patient that’s a permanent death sentence,” Parnia says.
Research is underway on the technology and methods that will shape new guidelines. Abella suspects that traditional CPR, for example, might need a makeover. CPR currently helps millions of people, but it uses a uniform approach of about 100 compressions per minute regardless of the patient. Abella and his colleagues’ research suggest that this life-saving practice may be more effective if it is dosed differently depending on the patient, much like medication.
Parnia’s group and others are developing what he calls a “GPS system that navigates the quality of care that patients are receiving.” The method, formally referred to as cerebral oximetry, uses near infrared spectroscopy that penetrates the skull and monitors how much oxygen reaches the brain during each beat of the heart or CPR chest compression. By knowing exactly how much oxygen is reaching the brain, doctors can adjust their CPR regime accordingly to minimise brain damage. “I see this becoming the standard of care, as opposed to doing CPR blindly as we have for decades,” Parnia says. He and his colleagues are already using cerebral oximetry in patients, and they will present some of their results at an upcoming American Heart Association meeting next month.
Smoothing out the recovery process is another priority. Currently, doctors induce mild hypothermia, as with Conrad’s case, for 24 hours. Whether that is the optimal time, however, is an open question.
In addition to using hypothermia, researchers are also figuring out ways to directly prevent cell death at the biological level. “There’s going to be all sorts of important discoveries in the coming years about tissue interaction and communication at the border of life and death,” Abella predicts.
One way to manipulate that process is to inject drugs that inhibit apoptosis, or programmed cell death. Some researchers are working on preventing damage by designing drugs that target the cells’ energy source, the mitochondria. Other groups are developing ways to block enzymes called calpains that induce cell death by acting like scissors and shredding proteins. In one laboratory experiment, rats that were asphyxiated for 10 minutes and given a calpain blocker had significantly less brain damage than those that received a placebo.
Despite the advances, there’s still much to learn. “We know quite a bit about how cells die,” Parnia says. “Where we’re lacking is how to switch off that process.” If that process becomes more clear, he imagines creating drugs that target those pathways and could be administered on the spot by emergency personnel to keep someone in a viable state, even in death, until they can reach a hospital. “I could inject you with a drug that prevents those pathways from causing your brain cells to become irreversibly damaged,” he says. “Then I hibernate you, transfer you to a hospital and hours later still have a chance of getting a whole person back.”
For patients that do survive, like Conrad, physical and neurological rehabilitation – methods that are still being worked out – may be necessary. Memory loss plagues some survivors, including Conrad. When he came back to life, he thought it was the year 2010. He got married two months before his accident, and although he remembered who his wife was, he had no recollection of their marriage. As days passed, however, his memory slowly returned. Now, he has a two-week memory blank starting at about noon on the day of the accident, but he’s grateful to have reclaimed full access to memories from before and after that event. Abella notes that these new rehabilitation problems are ones he’s happy to take on, however. People who today struggle with post-resuscitation issues would have just died ten years ago.
Those who are lucky enough to receive treatment, that is. Despite existing advances, today only an estimated 10% of patients in the US who are eligible for undergoing resuscitation techniques receive them. As Conrad noted, it was only “happenstance” that he received those potentially life-saving treatments, thanks to his wife’s – not his local hospital’s – insistence. The American Heart Association, the European Resuscitation Council and the equivalent entities in Canada, Australia and New Zealand published joint guidelines outlining state-of-the-art resuscitation procedures in 2008 and 2010, but many hospitals, for whatever reasons, still do not implement these methods. It’s not that hospitals don’t have the capability to induce hypothermia or monitor CPR efforts, Parnia says, but rather that they simply do not implement them. “That’s the biggest ethical dilemma – things are not being done that are currently available,” he says. “Most places are doing 20th Century – not 21st Century – resuscitation.”
It’s difficult, if not impossible, to predict how significantly survival could be boosted if promising technologies come to pass and hospitals implement them on a standardised, best-practice basis. Parnia ventures, however, that the survival figure could reach up to 50% in the next ten years.
No matter how advanced and standardised resuscitation science becomes, however, it almost certainly will never enable a Frankenstein-like situation. In the case of cadaver stem cells being rescued after 17 days, for example, those special cells alone survived the ravages of death. “The muscle itself is completely destroyed,” says Fabrice Chretien, a professor of histology at the Paris Descartes University and senior author of the stem cell work. “You cannot resuscitate the patient, and you cannot use his tissue for organ grafting,” he emphasises. “I’m only talking about one very special cell type.”
Likewise, after remaining dead for long enough, the basic structures that permit consciousness probably decay far beyond repair, Abella explains.
“We’re very interested in trying to resuscitate those who have suddenly lost their life in very recent minutes and hours,” Abella says. “I’m less interested in the business of bringing someone back from longer than that, and my suspicion is that it’s probably not possible.”
Immortality is not an option, either, at least not in the near term. Cardiac arrest is usually triggered by some underlying condition, such as coronary heart disease or diabetes; there is little meaning in bringing a terminal cancer patient back from the dead, only to make them suffer another agonising death hours or days later. Without finding a permanent fix for every disease, injury and condition that cause death, resuscitation only postpones the inevitable. Even if a healthy person, like Conrad, is brought back from the brink of death, eventually mortality will catch up. “Clearly there is a point at which it will be futile,” Parnia says.
For now, however, Conrad is rejoicing in his restored life and health. Abella and the other physicians were never able to determine what caused Conrad’s heart attack, but as a precaution, they implanted a tiny defibrillator in his chest. So far, he has not had cause to use it. He is enjoying married life and is back to working and biking again. “I still wake up pretty much every day and smile for a second,” he says. “If I’m stuck in traffic, I think to myself, ‘This is no big deal, it’s better to be breathing here than not at all.’”
While Conrad did not see a light at the end of the tunnel or gaze down at his body from above, he does wonder at the many small but significant coincidences that likely added up to save his life. He had randomly opted for a slightly different bike route that day, for example, which took him down a more populated path rather than his usual secluded one. He was lucky enough to be spotted by people with the compassion to stop and help a stranger in distress – one of which was an ER nurse who gave him CPR while waiting for the paramedics – and on top of that, he managed to find his way to Abella. “I’ve been incredibly lucky,” he says. “By all accounts very few people survive this.”
In an effort to “pay it forward”, Conrad attended a scientific conference on hypothermia treatment and gave a talk to the doctors in attendance about his experiences. “There are champions like Dr. Abella in various hospitals and communities all over the country, pushing the envelope on this,” he says. “I’m trying to cheer them on and tell them to keep going, because it can have can impact.”